Emergency Room Evaluation and Recommendations for Older Users of Emergency Departments

Emergency Room Evaluation and Recommendations for Older Users of Emergency Departments: a Cohort Study Database on the Effects of ER2 Recommendations on Length of Stay and Hospital Admission

The study evaluates if the Emergency Room Evaluation and Recommendation Tool (ER2) reduces the hospital admission rate and the length of stay in Emergency.

Study Overview

• Status: Active, not recruiting
• Conditions: Elderly Care; Multimorbidity; Length of Hospital Stay

Detailed Description

Regardless of the reason for ED visit and its care plan, there are simple interventions, which may be continued to prevent short-term ED adverse outcomes. Delirium, motor deconditioning, adverse drug reactions due to polypharmacy, and inappropriate home support are the main conditions to target when taking care of older ER users.

Evidence based medicine showed that simple and early intervention in the process of care may prevent delirium (e.g., hydration, avoid restraint, mobilize and satisfy basic needs, time and place reorientation) and motor deconditioning (e.g., encourage mobility, up to chair at meal time during day light hours, provide appropriate walking aid) in older patients. The medication reconciliation is also an efficient intervention for the prevention of adverse drug reactions. Furthermore, an early assessment of home support is a crucial step to adjust home services for an early discharge to home.

• Study Type: Observational
• Enrollment (Estimated): 4724

Contacts and Locations

Study Locations

• Canada
  • Quebec
    • Montréal, Quebec, Canada, H3T 1E2
      • Jewish General Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 75 years and older (Older Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

It will be enrolled participants who are 75 years and over, and who will be brought at Emergency on medical stretcher. At Emergency, nurses will carry out a test called: Emergency Room Evaluation and Recommendation.

Description

Inclusion Criteria:

• Being 75 years old and over
• Being brought at Emergency on medical stretcher

Exclusion Criteria:

• Being less than 75 years old
• Never come at Emergency

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Observational; At Emergency nurses will carry out a test called: Emergency Room Evaluation and Recommendation which contents the following statements: Being 85 years older and over (Yes/No); Male (Yes/No); Home services (Yes/No); Taking 5 different medication daily (Yes/No); Use of walking aid (Yes/No); Disoriented (Yes/No)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Hospital admission rate by age	The recommendation of the Emergency Room Evaluation Tool will be used to reduce the hospital admission rate in older at Emergency.	Around 10 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Length of stay at Emergency	The recommendation of the Emergency Room Evaluation Tool will be used to reduce the length of stay at Emergency.	Around 10 months

Collaborators and Investigators

• Sponsor: Jewish General Hospital
• Investigators: Principal Investigator: Olivier Beauchet, MD, Jewish General Hospital

Study record dates

Study Major Dates

• Study Start (Actual): July 23, 2019
• Primary Completion (Actual): February 1, 2022
• Study Completion (Estimated): September 1, 2024

Study Registration Dates

• First Submitted: July 15, 2019
• First Submitted That Met QC Criteria: July 15, 2019
• First Posted (Actual): July 17, 2019

Study Record Updates

• Last Update Posted (Estimated): February 23, 2024
• Last Update Submitted That Met QC Criteria: February 22, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: 2020-1851

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No